{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:21:55Z","timestamp":1773289315545,"version":"3.50.1"},"reference-count":117,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2010,11,11]],"date-time":"2010-11-11T00:00:00Z","timestamp":1289433600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s12032-010-9732-8","type":"journal-article","created":{"date-parts":[[2010,11,10]],"date-time":"2010-11-10T23:11:32Z","timestamp":1289430692000},"page":"675-684","source":"Crossref","is-referenced-by-count":14,"title":["Biochemical, pathological and oncological relevance of Gb3Cer receptor"],"prefix":"10.1007","volume":"28","author":[{"given":"D.","family":"\u0110evenica","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"\u010cike\u0161 \u010culi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Vuica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Markoti\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,11,11]]},"reference":[{"key":"9732_CR1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1023\/A:1026524820177","volume":"17","author":"SI Hakomori","year":"2000","unstructured":"Hakomori SI. Cell adhesion\/recognition and signal transduction through glycosphingolipid microdomain. Glycoconj J. 2000;17:143\u201351.","journal-title":"Glycoconj J"},{"key":"9732_CR2","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1021\/cr0100446","volume":"106","author":"S Sonnino","year":"2006","unstructured":"Sonnino S, Prinetti A, Mauri L, Chigorno V, Tettamanti G. Dynamic and structural properties of sphingolipids as driving forces for the formation of membrane domains. Chem Rev. 2006;106:2111\u201325.","journal-title":"Chem Rev"},{"key":"9732_CR3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1023\/A:1026580905156","volume":"17","author":"J Fantini","year":"2001","unstructured":"Fantini J, Maresca M, Hammache D, Yahi N, Del\u00e9zay O. Glycosphingolipid (GSL) microdomains as attachment platforms for host pathogens and their toxins on intestinal epithelial cells: activation of signal transduction pathways and perturbations of intestinal absorption and secretion. Glycoconj J. 2001;17:173\u20139.","journal-title":"Glycoconj J"},{"key":"9732_CR4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0076-6879(89)79122-9","volume":"179","author":"CL Stults","year":"1989","unstructured":"Stults CL, Sweeley CC, Macher BA. Glycosphingolipids: structure, biological source, and properties. Method Enzymol. 1989;179:167\u2013214.","journal-title":"Method Enzymol"},{"key":"9732_CR5","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/glycob\/1.5.477","volume":"1","author":"RL Schnaar","year":"1991","unstructured":"Schnaar RL. Glycosphingolipids in cell surface recognition. Glycobiology. 1991;1:477\u201385.","journal-title":"Glycobiology"},{"key":"9732_CR6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0966-842X(96)10017-2","volume":"4","author":"CA Lingwood","year":"1996","unstructured":"Lingwood CA. Role of verotoxin receptors in pathogenesis. Trends Microbiol. 1996;4:147\u201353.","journal-title":"Trends Microbiol"},{"key":"9732_CR7","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1128\/IAI.20.2.575-577.1978","volume":"20","author":"J Konowalchuk","year":"1978","unstructured":"Konowalchuk J, Dickie N, Stavric S, Speirs JI. Properties of an Escherichia coli cytotoxin. Infect Immun. 1978;20:575\u20137.","journal-title":"Infect Immun"},{"key":"9732_CR8","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/S0041-0101(01)00150-7","volume":"39","author":"K Sandvig","year":"2001","unstructured":"Sandvig K. Shiga toxins. Toxicon. 2001;39:1629\u201335.","journal-title":"Toxicon"},{"key":"9732_CR9","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1432-1033.1994.tb19064.x","volume":"223","author":"B Boyd","year":"1994","unstructured":"Boyd B, et al. Lipid modulation of glycolipid receptor function. Eur J Biochem. 1994;223:873\u20138.","journal-title":"Eur J Biochem"},{"key":"9732_CR10","doi-asserted-by":"crossref","first-page":"11138","DOI":"10.1016\/S0021-9258(19)78102-2","volume":"269","author":"A Kiarash","year":"1994","unstructured":"Kiarash A, et al. Glycosphingolipid receptor function is modified by fatty acid content. J Biol Chem. 1994;269:11138\u201346.","journal-title":"J Biol Chem"},{"key":"9732_CR11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF00731435","volume":"13","author":"CA Lingwood","year":"1996","unstructured":"Lingwood CA. Aglycone modulation of glycolipid receptor function. Glycoconj J. 1996;13:495\u2013503.","journal-title":"Glycoconj J"},{"key":"9732_CR12","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/(SICI)1097-4652(199812)177:4<646::AID-JCP15>3.0.CO;2-B","volume":"177","author":"S Arab","year":"1998","unstructured":"Arab S, Lingwood CA. Intracellular targeting of the endoplasmic reticulum\/nuclear envelope by retrograde transport may determine cell hypersensitivity to verotoxin via globotriaosyl ceramide fatty isoform traffic. J Cell Physiol. 1998;177:646\u201360.","journal-title":"J Cell Physiol"},{"key":"9732_CR13","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1021\/bi971806n","volume":"37","author":"H Ling","year":"1998","unstructured":"Ling H, et al. Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3. Biochemistry. 1998;37:1777\u201388.","journal-title":"Biochemistry"},{"key":"9732_CR14","doi-asserted-by":"crossref","first-page":"5943","DOI":"10.1093\/emboj\/19.22.5943","volume":"19","author":"K Sandvig","year":"2000","unstructured":"Sandvig K, van Deurs B. Entry of ricin and Shiga toxin into cells: molecular mechanisms and medical perspectives. EMBO J. 2000;19:5943\u201350.","journal-title":"EMBO J"},{"key":"9732_CR15","doi-asserted-by":"crossref","first-page":"10817","DOI":"10.1074\/jbc.270.18.10817","volume":"270","author":"O Garred","year":"1995","unstructured":"Garred O, van Deurs B, Sandvig K. Furin-induced cleavage and activation of Shiga toxin. J Biol Chem. 1995;270:10817\u201321.","journal-title":"J Biol Chem"},{"key":"9732_CR16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1432-1033.1988.tb13756.x","volume":"171","author":"Y Endo","year":"1988","unstructured":"Endo Y, et al. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and Shiga toxin on eukaryotic ribosomes. Eur J Biochem. 1988;171:45\u201350.","journal-title":"Eur J Biochem"},{"key":"9732_CR17","first-page":"5314","volume":"53","author":"M Mangeney","year":"1993","unstructured":"Mangeney M, et al. Apoptosis induced in Burkitt\u2019s lymphoma cells via Gb3\/CD77, a glycolipid antigen. Cancer Res. 1993;53:5314\u20139.","journal-title":"Cancer Res"},{"key":"9732_CR18","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.febslet.2009.10.051","volume":"584","author":"J Fan","year":"2010","unstructured":"Fan J, Sammalkorpi M, Haataja M. Formation and regulation of lipid microdomains in cell membranes: theory, modeling, and speculation. FEBS Lett. 2010;584:1678\u201384.","journal-title":"FEBS Lett"},{"key":"9732_CR19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1083\/jcb.200505047","volume":"171","author":"K Gaus","year":"2005","unstructured":"Gaus K, Chklovskaia E, Fazekas de Groth B, Jessup W, Harder T. Condensation of the plasma membrane at the site of T lymphocyte activation. J Cell Biol. 2005;171:121\u201331.","journal-title":"J Cell Biol"},{"key":"9732_CR20","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/ncb1492","volume":"8","author":"R Tavano","year":"2006","unstructured":"Tavano R, et al. CD28 interaction with filamin-A controls lipid raft accumulation at the T-cell immunological synapse. Nat Cell Biol. 2006;8:1270\u20136.","journal-title":"Nat Cell Biol"},{"key":"9732_CR21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1574-6968.2006.00545.x","volume":"266","author":"DJ Chinnapen","year":"2007","unstructured":"Chinnapen DJ, Chinnapen H, Saslowsky D, Lencer WI. Rafting with cholera toxin: endocytosis and trafficking from plasma membrane to ER. FEMS Microbiol Lett. 2007;266:129\u201337.","journal-title":"FEMS Microbiol Lett"},{"key":"9732_CR22","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/ijc.2910490607","volume":"49","author":"A Kalisiak","year":"1991","unstructured":"Kalisiak A, Minniti JG, Oosterwijk E, Old LJ, Scheinberg DA. Neutral glycosphingolipid expression in B-cell neoplasms. Int J Cancer. 1991;49:837\u201345.","journal-title":"Int J Cancer"},{"key":"9732_CR23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00418-001-0346-2","volume":"117","author":"K Sandvig","year":"2002","unstructured":"Sandvig K, et al. Pathways followed by ricin and Shiga toxin into cells. Histochem Cell Biol. 2002;117:131\u201341.","journal-title":"Histochem Cell Biol"},{"key":"9732_CR24","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nrm1985","volume":"7","author":"JS Bonifacino","year":"2006","unstructured":"Bonifacino JS, Rojas R. Retrograde transport from endosomes to the trans-Golgi network. Nat Rev Mol Cell Biol. 2006;7:568\u201379.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9732_CR25","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nature05996","volume":"450","author":"W R\u00f6mer","year":"2007","unstructured":"R\u00f6mer W, et al. Shiga toxin induces tubular membrane invaginations for its uptake into cells. Nature. 2007;450:670\u20135.","journal-title":"Nature"},{"key":"9732_CR26","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/S0301-472X(00)00538-5","volume":"28","author":"T Mori","year":"2000","unstructured":"Mori T, et al. Globotriaosyl ceramide (CD77\/Gb3) in the glycolipidenriched membrane domain participates in B-cell receptor-mediated apoptosis by regulating Lyn kinase activity in human B cells. Exp Hematol. 2000;28:1260\u20138.","journal-title":"Exp Hematol"},{"key":"9732_CR27","doi-asserted-by":"crossref","first-page":"35278","DOI":"10.1074\/jbc.274.49.35278","volume":"274","author":"YU Katagiri","year":"1999","unstructured":"Katagiri YU, et al. Activation of Src family kinase yes induced by Shiga toxin binding to globotriaosyl ceramide (Gb3\/CD77) in low density, detergent-insoluble microdomains. J Biol Chem. 1999;274:35278\u201382.","journal-title":"J Biol Chem"},{"key":"9732_CR28","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1091\/mbc.12.8.2453","volume":"12","author":"T Falgui\u00e8res","year":"2001","unstructured":"Falgui\u00e8res T, et al. Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent resistant membranes. Mol Biol Cell. 2001;12:2453\u201368.","journal-title":"Mol Biol Cell"},{"key":"9732_CR29","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1242\/jcs.114.22.4025","volume":"114","author":"O Kovbasnjuk","year":"2001","unstructured":"Kovbasnjuk O, et al. Role of lipid rafts in Shiga toxin 1 interaction with the apical surface of Caco-2 cells. J Cell Sci. 2001;114:4025\u201331.","journal-title":"J Cell Sci"},{"key":"9732_CR30","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.bbamcr.2005.07.007","volume":"1746","author":"WI Lencer","year":"2005","unstructured":"Lencer WI, Saslowsky D. Raft trafficking of AB5 subunit bacterial toxins. Biochim Biophys Acta. 2005;1746:314\u201321.","journal-title":"Biochim Biophys Acta"},{"key":"9732_CR31","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1099\/mic.0.2007\/006858-0","volume":"153","author":"P Tam","year":"2007","unstructured":"Tam P, Lingwood C. Membrane-cytosolic translocation of verotoxin A1-subunit in target cells. Microbiology. 2007;153:2700\u201310.","journal-title":"Microbiology"},{"key":"9732_CR32","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2010.01.010","volume":"140","author":"W R\u00f6mer","year":"2010","unstructured":"R\u00f6mer W, et al. Actin dynamics drive membrane reorganization and scission in clathrin-independent endocytosis. Cell. 2010;140:540\u201353.","journal-title":"Cell"},{"key":"9732_CR33","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1023\/A:1020261125008","volume":"27","author":"B Binnington","year":"2002","unstructured":"Binnington B, Lingwood D, Nutikka A, Lingwood CA. Effect of globotriaosyl ceramide fatty acid a-hydroxylation on the binding by verotoxin 1 and verotoxin 2. Neurochem Res. 2002;27:807\u201313.","journal-title":"Neurochem Res"},{"key":"9732_CR34","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/infdis\/168.2.476","volume":"168","author":"D Newburg","year":"1993","unstructured":"Newburg D, et al. Susceptibility to hemolytic-uremic syndrome relates to erythrocyte glycosphingolipid patterns. J Infect Dis. 1993;168:476\u20139.","journal-title":"J Infect Dis"},{"key":"9732_CR35","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1023\/A:1020299819637","volume":"19","author":"CA Lingwood","year":"1999","unstructured":"Lingwood CA. Verotoxin\/globotriaosyl ceramide recognition: angiopathy, angiogenesis and antineoplasia. Biosci Rep. 1999;19:345\u201354.","journal-title":"Biosci Rep"},{"key":"9732_CR36","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/j.1349-7006.2006.00326.x","volume":"97","author":"K Kiguchi","year":"2006","unstructured":"Kiguchi K, et al. Characteristic expression of globotriaosyl ceramide in human ovarian carcinomaderived cells with anticancer drug resistance. Cancer Sci. 2006;97:1321\u20136.","journal-title":"Cancer Sci"},{"key":"9732_CR37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1083\/jcb.126.1.53","volume":"126","author":"K Sandvig","year":"1994","unstructured":"Sandvig K, et al. Retrograde transport from the golgi complex to the ER of both Shiga toxin and the nontoxic Shiga B-fragment is regulated by butyric acid and cAMP. J Cell Biol. 1994;126:53\u201364.","journal-title":"J Cell Biol"},{"key":"9732_CR38","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/jcp.21456","volume":"216","author":"P Tam","year":"2008","unstructured":"Tam P, et al. Differential intracellular trafficking and binding of verotoxin 1 and verotoxin 2 to globotriaosylceramide-containing lipid assemblies. J Cell Physiol. 2008;216:750\u201363.","journal-title":"J Cell Physiol"},{"key":"9732_CR39","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/PL00000643","volume":"57","author":"K Burger","year":"2000","unstructured":"Burger K, Gimpl G, Fahrenholz F. Regulation of receptor function by cholesterol. Cell Mol Life Sci. 2000;57:1577\u201392.","journal-title":"Cell Mol Life Sci"},{"key":"9732_CR40","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1432-1033.2003.03941.x","volume":"271","author":"D Chark","year":"2004","unstructured":"Chark D, Nutikka A, Trusevych N, Kuzmina J, Lingwood C. Differential carbohydrate epitope recognition of globotriaosyl ceramide by verotoxins and a monoclonal antibody. Eur J Bioch. 2004;271:405\u201317.","journal-title":"Eur J Bioch"},{"key":"9732_CR41","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1091\/mbc.E05-11-1035","volume":"17","author":"DC Smith","year":"2006","unstructured":"Smith DC, et al. The association of Shiga-like toxin with detergent-resistant membranes is modulated by glucosylceramide and is an essential requirement in the endoplasmic reticulum for a cytotoxic effect. Mol Biol Cell. 2006;17:1375\u201387.","journal-title":"Mol Biol Cell"},{"key":"9732_CR42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1462-5822.2003.00254.x","volume":"5","author":"DEE Hoey","year":"2003","unstructured":"Hoey DEE, Currie C, Lingwood CA, Gally DL, Smith DGE. Binding of verotoxin 1 to primary intestinal epithelial cells expressing Gb3 results in trafficking of toxin to lysosomal compartments. Cell Microbiol. 2003;5:85\u201397.","journal-title":"Cell Microbiol"},{"key":"9732_CR43","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/(SICI)1097-4652(199808)176:2<281::AID-JCP6>3.0.CO;2-K","volume":"176","author":"AA Khine","year":"1998","unstructured":"Khine AA, Firtel M, Lingwood CA. CD77-dependent retrograde transport of CD19 to the nuclear membrane: functional relationship between CD77 and CD19 during germinal center B-cell apoptosis. J Cell Physiol. 1998;176:281\u201392.","journal-title":"J Cell Physiol"},{"key":"9732_CR44","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1084\/jem.180.1.191","volume":"180","author":"MD Maloney","year":"1994","unstructured":"Maloney MD, Lingwood CA. CD19 Has a potential CD77 (Globotriaosyl ceramide)-binding site with sequence similarity to verotoxin B-subunits: implications of molecular mimicry for B cell adhesion and enterohemorrhagic Escherichia coli pathogenesis. J Exp Med. 1994;180:191\u2013201.","journal-title":"J Exp Med"},{"key":"9732_CR45","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1128\/IAI.56.9.2373-2378.1988","volume":"56","author":"TG Obrig","year":"1988","unstructured":"Obrig TG, et al. Direct cytotoxic action of Shiga toxin on human vascular endothelial cells. Infect Immun. 1988;56:2373\u20138.","journal-title":"Infect Immun"},{"key":"9732_CR46","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/bbrc.1998.9417","volume":"251","author":"K Ohmi","year":"1998","unstructured":"Ohmi K, Kiyokawa N, Takeda T, Fujimoto J. Human microvascular endothelial cells are strongly sensitive to Shiga toxin. Biochem Biophys Res Commun. 1998;251:137\u201341.","journal-title":"Biochem Biophys Res Commun"},{"key":"9732_CR47","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/oxfordjournals.jbchem.a123530","volume":"110","author":"J Holgersson","year":"1991","unstructured":"Holgersson J, Jovall PA, Breimer ME. Glycosphingolipids of human large intestine: detailed structural characterization with special reference to blood group compounds and bacterial receptor structures. J Biochem. 1991;110:120\u201331.","journal-title":"J Biochem"},{"key":"9732_CR48","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1046\/j.1462-5822.2004.00370.x","volume":"6","author":"S Schuller","year":"2004","unstructured":"Schuller S, Frankel G, Phillips AD. Interaction of Shiga toxin from Escherichia coli with human intestinal epithelial cell lines and explants: Stx2 induces epithelial damage in organ culture. Cell Microbiol. 2004;6:289\u2013301.","journal-title":"Cell Microbiol"},{"key":"9732_CR49","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1086\/314982","volume":"180","author":"B Ramegowda","year":"1999","unstructured":"Ramegowda B, Samuel JE, Tesh VL. Interaction of Shiga toxins with human brain microvascular endothelial cells: cytokines as sensitizing agents. J Infect Dis. 1999;180:1205\u201313.","journal-title":"J Infect Dis"},{"key":"9732_CR50","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1128\/IAI.69.3.1889-1894.2001","volume":"69","author":"PE Eisenhauer","year":"2001","unstructured":"Eisenhauer PE, et al. Tumor necrosis factor alpha increases human cerebral endothelial cell Gb3 and sensitivity to Shiga toxin. Infect Immun. 2001;69:1889\u201394.","journal-title":"Infect Immun"},{"key":"9732_CR51","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1086\/344053","volume":"186","author":"PK Stricklett","year":"2002","unstructured":"Stricklett PK, Hughes AK, Ergonul Z, Kohan DE. Molecular basis for up-regulation by inflammatory cytokines of Shiga toxin 1 cytotoxicity and globotriaosylceramide expression. J Infect Dis. 2002;186:976\u201382.","journal-title":"J Infect Dis"},{"key":"9732_CR52","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1086\/345861","volume":"187","author":"Z Ergonul","year":"2003","unstructured":"Ergonul Z, Hughes AK, Kohan DE. Induction of apoptosis of human brain microvascular endothelial cells by Shiga toxin. J Infect Dis. 2003;187:154\u20138.","journal-title":"J Infect Dis"},{"key":"9732_CR53","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1086\/315131","volume":"180","author":"H Uchida","year":"1999","unstructured":"Uchida H, et al. Shiga toxins induce apoptosis in pulmonary epithelium\u2013derived cells. J Infect Dis. 1999;180:1902\u201311.","journal-title":"J Infect Dis"},{"key":"9732_CR54","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1742-2094-5-11","volume":"5","author":"K Takahashi","year":"2008","unstructured":"Takahashi K, Funata N, Ikuta F, Sato S. Neuronal apoptosis and inflammatory responses in the central nervous system of a rabbit treated with Shiga toxin-2. J Neuroinflamm. 2008;5:11\u201323.","journal-title":"J Neuroinflamm"},{"key":"9732_CR55","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1074\/jbc.M705473200","volume":"283","author":"MF Rosa De","year":"2008","unstructured":"De Rosa MF, et al. Inhibition of multidrug resistance by adamantylgb3, a globotriasylceramide analog. J Biol Chem. 2008;283:4501\u201311.","journal-title":"J Biol Chem"},{"key":"9732_CR56","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1160\/TH05-04-0265","volume":"94","author":"M Bielaszewska","year":"2005","unstructured":"Bielaszewska M, Karch H. Consequences of enterohaemorrhagic Escherichia coli infection for the vascular endothelium. Thromb Haemost. 2005;94:312\u20138.","journal-title":"Thromb Haemost"},{"key":"9732_CR57","first-page":"299","volume":"9","author":"H Nakao","year":"2000","unstructured":"Nakao H, Takeda T. Escherichia coli Shiga toxin. J Nat Toxins. 2000;9:299\u2013313.","journal-title":"J Nat Toxins"},{"key":"9732_CR58","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1055\/s-2001-15250","volume":"27","author":"H Karch","year":"2001","unstructured":"Karch H. The role of virulence factors in enterohemorrhagic Escherichia coli (EHEC)-associated hemolytic: uremic syndrome. Semin Thromb Hemost. 2001;27:207\u201313.","journal-title":"Semin Thromb Hemost"},{"key":"9732_CR59","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0140-6736(89)90591-6","volume":"2","author":"KD Forsyth","year":"1989","unstructured":"Forsyth KD, et al. Neutrophil-mediated endothelial injury in haemolytic uraemic syndrome. Lancet. 1989;2:411\u20134.","journal-title":"Lancet"},{"key":"9732_CR60","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1182\/blood.V98.6.1828","volume":"98","author":"M Morigi","year":"2001","unstructured":"Morigi M, et al. Verotoxin-1-induced up-regulation of adhesive molecules renders microvascular endothelial cells thrombogenic at high shear stress. Blood. 2001;98:1828\u201335.","journal-title":"Blood"},{"key":"9732_CR61","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.1128\/IAI.70.8.4669-4677.2002","volume":"70","author":"JC Ching","year":"2002","unstructured":"Ching JC, Jones NL, Ceponis PJ, Karmali MA, Sherman PM. Escherichia coli shiga-like toxins induce apoptosis and cleavage of poly (ADP-ribose) polymerase via in vitro activation of caspases. Infect Immun. 2002;70:4669\u201377.","journal-title":"Infect Immun"},{"key":"9732_CR62","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/1097-4644(20010401)81:1<128::AID-JCB1029>3.0.CO;2-G","volume":"81","author":"N Kiyokawa","year":"2001","unstructured":"Kiyokawa N, et al. Activation of the caspase cascade during Stx1-induced apoptosis in Burkitt\u2019s lymphoma cells. J Cell Biochem. 2001;81:128\u201342.","journal-title":"J Cell Biochem"},{"key":"9732_CR63","doi-asserted-by":"crossref","first-page":"45200","DOI":"10.1074\/jbc.M303868200","volume":"278","author":"C T\u00e9taud","year":"2003","unstructured":"T\u00e9taud C, et al. Two distinct Gb3\/CD77 signaling pathways leading to apoptosis are triggered by anti-Gb3\/CD77 mAb and verotoxin-1. J Biol Chem. 2003;278:45200\u20138.","journal-title":"J Biol Chem"},{"key":"9732_CR64","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cellsig.2009.10.018","volume":"22","author":"J Garibal","year":"2001","unstructured":"Garibal J, Hollville \u00c9, Renouf B, T\u00e9taud C, Wiels J. Caspase-8-mediated cleavage of Bid and protein phosphatase 2A-mediated activation of Bax is necessary for Verotoxin-1-induced apoptosis in Burkitt\u2019s lymphoma cells. Cell Signal. 2001;22:467\u201375.","journal-title":"Cell Signal"},{"key":"9732_CR65","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1128\/IAI.73.8.5115-5126.2005","volume":"73","author":"SY Lee","year":"2008","unstructured":"Lee SY, Cherla RP, Caliskan I, Tesh VL. Shiga toxin 1 induces apoptosis in the human myelogenous leukemia cell line THP-1 by a caspase-8-dependent, tumor necrosis factor-independent mechanism. Infect Immun. 2008;73:5115\u201326.","journal-title":"Infect Immun"},{"key":"9732_CR66","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0882-4010(03)00100-1","volume":"35","author":"RD Erwert","year":"2003","unstructured":"Erwert RD, et al. Shiga toxin induces decreased expression of the anti-apoptotic protein Mcl-1 concomitant with the onset of endothelial apoptosis. Microb Pathog. 2003;35:87\u201393.","journal-title":"Microb Pathog"},{"key":"9732_CR67","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1128\/IAI.71.5.2724-2735.2003","volume":"71","author":"J Fujii","year":"2003","unstructured":"Fujii J, et al. Rapid apoptosis induced by Shiga toxin in HeLa cells. Infect Immun. 2003;71:2724\u201335.","journal-title":"Infect Immun"},{"key":"9732_CR68","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1040-8428(01)00126-3","volume":"39","author":"J Gariepy","year":"2001","unstructured":"Gariepy J. The use of Shiga-like toxin 1 in cancer therapy. Crit Rev Oncol Hematol. 2001;39:99\u2013106.","journal-title":"Crit Rev Oncol Hematol"},{"key":"9732_CR69","first-page":"2901","volume":"94","author":"EC LaCasse","year":"1999","unstructured":"LaCasse EC, et al. Shiga-like toxin-1 receptor on human breast cancer, lymphoma, myeloma and absence from CD34(+) hematopoietic stem cells: implications for ex vivo tumor purging and autologous stem cell transplantation. Blood. 1999;94:2901\u201310.","journal-title":"Blood"},{"key":"9732_CR70","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/sj.neo.7900243","volume":"4","author":"B Salhia","year":"2002","unstructured":"Salhia B, Rutka JT, Lingwood C, Nutikka A, Van Furth WR. The treatment of malignant meningioma with verotoxin. Neoplasia. 2002;4:304\u201311.","journal-title":"Neoplasia"},{"key":"9732_CR71","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/ijc.2910360508","volume":"36","author":"LJ Murray","year":"1985","unstructured":"Murray LJ, Habeshaw JA, Wiels J, Greaves MF. Expression of Burkitt lymphoma-associated antigen (defined by the monoclonal antibody 38.13) on both normal and malignant germinal-centre B cells. Int J Cancer. 1985;36:561\u20135.","journal-title":"Int J Cancer"},{"key":"9732_CR72","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/ijc.2910450610","volume":"45","author":"C Ohyama","year":"1990","unstructured":"Ohyama C, et al. Changes in glycolipid expression in human testicular tumor. Int J Cancer. 1990;45:1040\u20134.","journal-title":"Int J Cancer"},{"key":"9732_CR73","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.4161\/cbt.5.9.3173","volume":"5","author":"D Johansson","year":"2006","unstructured":"Johansson D, et al. Verotoxin-1 induction of apoptosis in Gb3- expressing human glioma cell lines. Cancer Biol Ther. 2006;5:1211\u20137.","journal-title":"Cancer Biol Ther"},{"key":"9732_CR74","first-page":"553","volume":"9","author":"S Arab","year":"1997","unstructured":"Arab S, et al. Expression of the verotoxin receptor glycolipid, globotriaosylceramide, in ovarian hyperplasias. Oncol Res. 1997;9:553\u201363.","journal-title":"Oncol Res"},{"key":"9732_CR75","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2165\/00063030-200317030-00002","volume":"17","author":"P Fredman","year":"2003","unstructured":"Fredman P, Hedberg K, Brezicka T. Gangliosides as therapeutic targets for cancer. BioDrugs. 2003;17:155\u201367.","journal-title":"BioDrugs"},{"key":"9732_CR76","doi-asserted-by":"crossref","first-page":"19087","DOI":"10.1073\/pnas.0506474102","volume":"102","author":"O Kovbasnjuk","year":"2005","unstructured":"Kovbasnjuk O, et al. The glycosphingolipid globotriaosylceramide in the metastatic transformation of colon cancer. Proc Natl Acad Sci USA. 2005;102:19087\u201392.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9732_CR77","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/sj.gt.3302557","volume":"12","author":"L Johannes","year":"2005","unstructured":"Johannes L, Decaudin D. Protein toxins: intracellular trafficking for targeted therapy. Gene Ther. 2005;12:1360\u20138.","journal-title":"Gene Ther"},{"key":"9732_CR78","doi-asserted-by":"crossref","first-page":"7230","DOI":"10.1158\/0008-5472.CAN-06-0631","volume":"66","author":"KP Janssen","year":"2006","unstructured":"Janssen KP, et al. In vivo tumor targeting using a novel intestinal pathogen-based delivery approach. Cancer Res. 2006;66:7230\u20136.","journal-title":"Cancer Res"},{"key":"9732_CR79","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1128\/JCM.39.6.2272-2279.2001","volume":"39","author":"K Ludwig","year":"2001","unstructured":"Ludwig K, et al. Antibody response to Shiga toxins Stx2 and Stx1 in children with enteropathic hemolytic-uremic syndrome. J Clin Microbiol. 2001;39:2272\u20139.","journal-title":"J Clin Microbiol"},{"key":"9732_CR80","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1128\/JCM.30.7.1636-1641.1992","volume":"30","author":"MM Levine","year":"1992","unstructured":"Levine MM, et al. Antibodies to shiga holotoxin and to two synthetic peptides of the B subunit in sera of patients with Shigella dysenteriae 1 dysentery. J Clin Microbiol. 1992;30:1636\u201341.","journal-title":"J Clin Microbiol"},{"key":"9732_CR81","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-3-642-77238-2_4","volume":"180","author":"AD O\u2019Brien","year":"1992","unstructured":"O\u2019Brien AD, et al. Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis. Curr Top Microbiol Immunol. 1992;180:65\u201394.","journal-title":"Curr Top Microbiol Immunol"},{"key":"9732_CR82","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/eji.200535443","volume":"36","author":"B Vingert","year":"2006","unstructured":"Vingert B, et al. The Shiga toxin B-subunit targets antigen in vivo to dendritic cells and elicits anti-tumor immunity. Eur J Immunol. 2006;36:1124\u201335.","journal-title":"Eur J Immunol"},{"key":"9732_CR83","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.4049\/jimmunol.165.6.3301","volume":"165","author":"N Haicheur","year":"2000","unstructured":"Haicheur N, et al. Vt B-subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I restricted presentation of peptides derived from exogenous antigens. J Immunol. 2000;165:3301\u20138.","journal-title":"J Immunol"},{"key":"9732_CR84","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1073\/pnas.97.2.847","volume":"97","author":"H Wang","year":"2000","unstructured":"Wang H, Griffiths MN, Burton DR, Ghazal P. Rapid antibody responses by low-dose, single-step, dendritic cell-targeted immunization. Proc Natl Acad Sci USA. 2000;97:847\u201385.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9732_CR85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/intimm\/dxg001","volume":"15","author":"N Haicheur","year":"2003","unstructured":"Haicheur N, et al. The B subunit of Shiga toxin coupled to fullsize antigenic protein elicits humoral and cell-mediated immune responses associated with a Th1-dominant polarization. Int Immunol. 2003;15:1\u201311.","journal-title":"Int Immunol"},{"key":"9732_CR86","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1158\/1535-7163.MCT-08-0430","volume":"7","author":"T Falgui\u00e8res","year":"2008","unstructured":"Falgui\u00e8res T. Human colorectal tumors and metastases express Gb3 and can be targeted by an intestinal pathogen-based delivery tool. Mol Cancer Ther. 2008;7:2498\u2013508.","journal-title":"Mol Cancer Ther"},{"key":"9732_CR87","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2310\/7290.2008.00022","volume":"7","author":"T Viel","year":"2008","unstructured":"Viel T, et al. In vivo tumor targeting by the B-subunit of shiga toxin. Mol Imaging. 2008;7:239\u201347.","journal-title":"Mol Imaging"},{"key":"9732_CR88","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1046\/j.1523-1755.2002.00502.x","volume":"62","author":"NW Rutjes","year":"2002","unstructured":"Rutjes NW, Binnington BA, Smith CR, Maloney MD, Lingwood CA. Differential tissue targeting and pathogenesis of verotoxins 1 and 2 in the mouse animal model. Kidney Int. 2002;62:832\u201345.","journal-title":"Kidney Int"},{"key":"9732_CR89","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.micinf.2003.10.016","volume":"6","author":"A Imberty","year":"2004","unstructured":"Imberty A, Wimmerov\u00e1 M, Mitchell EP, Gilboa-Garber N. Structures of the lectins from Pseudomonas aeruginosa: insight into the molecular basis for host glycan recognition. Microbes Infect. 2004;6:221\u20138.","journal-title":"Microbes Infect"},{"key":"9732_CR90","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jmb.2008.08.028","volume":"383","author":"B Blanchard","year":"2008","unstructured":"Blanchard B, et al. Structural basis of the preferential binding for globo-series glycosphingolipids displayed by Pseudomonas aeruginosa lectin I. Mol Biol. 2008;383:837\u201353.","journal-title":"Mol Biol"},{"issue":"8","key":"9732_CR91","doi-asserted-by":"crossref","first-page":"e6813","DOI":"10.1371\/journal.pone.0006813","volume":"4","author":"U BDistler","year":"2009","unstructured":"Distler U, et al. Shiga toxin receptor Gb3Cer\/CD77: tumor-association and promising therapeutic target in pancreas and colon cancer. PLoS ONE. 2009;4(8):e6813.","journal-title":"PLoS ONE"},{"key":"9732_CR92","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.micinf.2006.10.005","volume":"9","author":"S Schuller","year":"2007","unstructured":"Schuller S, Heuschkel R, Torrente F, Kaper JB, Phillips AD. Shiga toxin binding in normal and inflamed human intestinal mucosa. Microbes Infect. 2007;9:35\u20139.","journal-title":"Microbes Infect"},{"key":"9732_CR93","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/01.ju.0000100110.11129.85","volume":"171","author":"S Ishitoya","year":"2004","unstructured":"Ishitoya S, et al. Verotoxin induces rapid elimination of human renal tumor xenografts in SCID mice. J Urol. 2004;171:1309\u201313.","journal-title":"J Urol"},{"key":"9732_CR94","first-page":"33","volume":"11","author":"S Arab","year":"1999","unstructured":"Arab S, Rutka J, Lingwood C. Verotoxin induces apoptosis and the complete, rapid, long-term elimination of human astrocytoma xenografts in nude mice. Oncol Res. 1999;11:33\u20139.","journal-title":"Oncol Res"},{"key":"9732_CR95","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1023\/B:AGEN.0000011799.47529.fd","volume":"6","author":"HM Heath-Engel","year":"2003","unstructured":"Heath-Engel HM, Lingwood CA. Verotoxin sensitivity of ECV304 cells in vitro and in vivo in a xenograft tumour model: VT1 as a tumour neovascular marker. Angiogenesis. 2003;6:129\u201341.","journal-title":"Angiogenesis"},{"key":"9732_CR96","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1471-2407-9-67","volume":"9","author":"D Johansson","year":"2009","unstructured":"Johansson D, et al. Expression of verotoxin-1 receptor Gb3 in breast cancer tissue and verotoxin-1 signal transduction to apoptosis. BMC Cancer. 2009;9:67\u201376.","journal-title":"BMC Cancer"},{"key":"9732_CR97","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000216407","volume":"10","author":"GW Bornkamm","year":"1987","unstructured":"Bornkamm GW, Polack A, Eick D, Berger R, Lenoir GM. Chromosome translocations and Epstein-Barr virus in Burkitt\u2019s lymphoma. Onkologie. 1987;10:196\u2013204.","journal-title":"Onkologie"},{"key":"9732_CR98","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1182\/blood.V93.3.1124","volume":"3","author":"ES Jaffe","year":"1999","unstructured":"Jaffe ES, et al. Burkitt\u2019s lymphoma: a single disease with multiple variants. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Blood. 1999;3:1124.","journal-title":"Blood"},{"key":"9732_CR99","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/sj.cdd.4400710","volume":"7","author":"J Gordon","year":"2000","unstructured":"Gordon J, et al. CD40 ligand, Bcl-2, and Bcl-xL spare group I Burkitt lymphoma cells from CD77-directed killing via Verotoxin-1B chain but fail to protect against the holotoxin. Cell Death Differ. 2000;7:785\u201394.","journal-title":"Cell Death Differ"},{"key":"9732_CR100","doi-asserted-by":"crossref","first-page":"17088","DOI":"10.1016\/S0021-9258(18)45495-6","volume":"262","author":"A Cohen","year":"1987","unstructured":"Cohen A, Hannigan GE, Williams BRG, Lingwood CA. Roles of globotriosyl- and galabiosylceramide in verotoxin binding and high affinity interferon receptor. J Biol Chem. 1987;262:17088\u201391.","journal-title":"J Biol Chem"},{"key":"9732_CR101","doi-asserted-by":"crossref","first-page":"6485","DOI":"10.1073\/pnas.78.10.6485","volume":"78","author":"J Wiels","year":"1981","unstructured":"Wiels J, Fellous M, Tursz T. Monoclonal antibody against a Burkitt lymphoma associated antigen. Proc Natl Acad Sci USA. 1981;78:6485\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9732_CR102","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/ijc.2910430415","volume":"43","author":"R Sakthivel","year":"1989","unstructured":"Sakthivel R, Christensson B, Ehlin-Henriksson B, Klein G. Immunophenotypic characterization of follicle-center-cell-derived non-Hodgkin\u2019s lymphomas. Int J Cancer. 1989;43:624\u201330.","journal-title":"Int J Cancer"},{"key":"9732_CR103","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1182\/blood.V90.7.2757","volume":"90","author":"S Taga","year":"1997","unstructured":"Taga S, et al. Intracellular signalling events in CD77-mediated apoptosis of Burkitt\u2019s lymphoma cells. Blood. 1997;90:2757\u201367.","journal-title":"Blood"},{"key":"9732_CR104","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/cimm.1997.1205","volume":"182","author":"G Grafton","year":"1997","unstructured":"Grafton G, Goodall M, Gregory CD, Gordon J. Mechanisms of antigen receptor-dependent apoptosis in human B lymphoma cell lines probed with a panel of 27 monoclonal antibodies. Cell Immunol. 1997;182:45\u201356.","journal-title":"Cell Immunol"},{"key":"9732_CR105","first-page":"3600","volume":"57","author":"JM Michael","year":"1997","unstructured":"Michael JM, Lavin MF, Watters DJ. Resistance to radiation-induced apoptosis in Burkitt\u2019s lymphoma cells is associated with defective ceramide signaling. Cancer Res. 1997;57:3600\u20135.","journal-title":"Cancer Res"},{"key":"9732_CR106","doi-asserted-by":"crossref","first-page":"11247","DOI":"10.1074\/jbc.M109519200","volume":"277","author":"K Furukawa","year":"2002","unstructured":"Furukawa K, et al. Expression of the Gb3\/CD77 synthase gene in megakaryoblastic leukemia cells. J Biol Chem. 2002;277:11247\u201354.","journal-title":"J Biol Chem"},{"key":"9732_CR107","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1182\/blood.V83.12.3654.3654","volume":"83","author":"X-g Zhang","year":"1994","unstructured":"Zhang X-g, et al. Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma. Blood. 1994;83:3654\u201363.","journal-title":"Blood"},{"key":"9732_CR108","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1182\/blood.V92.8.2844","volume":"92","author":"AJ Szczepek","year":"1998","unstructured":"Szczepek AJ, et al. A high frequency of circulating B cells share clonotypic IgH VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single cell and in situ RT-PCR. Blood. 1998;92:2844\u201355.","journal-title":"Blood"},{"key":"9732_CR109","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1182\/blood-2005-06-2342","volume":"106","author":"D Bechtel","year":"2005","unstructured":"Bechtel D, Kurth J, Unkel C, Ku\u00a8ppers R. Transformation of BCR-deficient germinal-center B cells by EBV supports a major role of the virus in the pathogenesis of Hodgkin and posttransplantation lymphomas. Blood. 2005;106:4345\u201350.","journal-title":"Blood"},{"key":"9732_CR110","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0145-2126(00)00060-6","volume":"24","author":"GS Arbus","year":"2000","unstructured":"Arbus GS, et al. Verotoxin targets lymphoma infiltrates of patients with post-transplant lymphoproliferative disease. Leukemia Res. 2000;24:857\u201364.","journal-title":"Leukemia Res"},{"key":"9732_CR111","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/cimm.2000.1616","volume":"200","author":"A Craxton","year":"2000","unstructured":"Craxton A, Chuang PI, Shu G, Harlan JM, Clark EA. The CD40-inducible Bcl-2 family member A1 protects B Cells from antigen receptor-mediated apoptosis. Cell Immunol. 2000;200:56\u201362.","journal-title":"Cell Immunol"},{"key":"9732_CR112","first-page":"107","volume":"7","author":"T Li","year":"1996","unstructured":"Li T, Ramirez K, Palacios R. Distinct patterns of Fas cell surface expression during development of T- or B-lymphocyte lineages in normal, scid, and mutant mice lacking or overexpressing p53, bcl-2, or rag-2 genes. Cell Growth Differ. 1996;7:107\u201314.","journal-title":"Cell Growth Differ"},{"key":"9732_CR113","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1182\/blood.V91.1.244","volume":"91","author":"P Ghia","year":"1998","unstructured":"Ghia P, et al. Unbalanced expression of Bcl-2 family proteins in follicular lymphoma: contribution of CD40 signaling in promoting survival. Blood. 1998;91:224\u201351.","journal-title":"Blood"},{"key":"9732_CR114","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/eji.1830230948","volume":"23","author":"MJ Holder","year":"1993","unstructured":"Holder MJ, et al. Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bcl-2 induction. Eur J Immunol. 1993;23:2368\u201371.","journal-title":"Eur J Immunol"},{"key":"9732_CR115","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1517\/14796694.1.3.297","volume":"1","author":"C Traulle","year":"2005","unstructured":"Traulle C, Coiffier B. Evolving role of rituximab in the treatment of patients with non-Hodgkin\u2019s lymphoma. Future Oncol. 2005;1:297\u2013306.","journal-title":"Future Oncol"},{"key":"9732_CR116","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/10446670410001670454","volume":"11","author":"L B\u00e9niguel","year":"2004","unstructured":"B\u00e9niguel L, et al. identification of germinal center B cells in blood from HIV-infected drug-naive individuals in central Africa. Clin Dev Immunol. 2004;11:23\u20137.","journal-title":"Clin Dev Immunol"},{"key":"9732_CR117","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/glycob\/cwn106","volume":"19","author":"S Ramkumar","year":"2009","unstructured":"Ramkumar S, Sakac D, Binnington B, Branch DR, Lingwood CA. Induction of HIV-1 resistance: cell susceptibility to infection is an inverse function of globotriaosyl ceramide levels. Glycobiology. 2009;19:76\u201382.","journal-title":"Glycobiology"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-010-9732-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-010-9732-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-010-9732-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T05:05:31Z","timestamp":1685855131000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-010-9732-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,11]]},"references-count":117,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["9732"],"URL":"https:\/\/doi.org\/10.1007\/s12032-010-9732-8","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,11]]}}}